Abstract
Quality of Life in Newly Diagnosed Patients with Multiple Myeloma Randomized to Either Krd or Ktd Induction Therapy Followed By Carfilzomib Maintenance or Control (AGMT MM 02 trial)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have